|
|
Office Locations:
|
1014 Market St., Suite 200
Kirkland, WA 98033
| | |
|
|
|
|
|
Consumer Products & Services
Food & Agriculture
Life Sciences & Healthcare
Medical Device
|
|
|
|
Altitude Life Science Ventures seeks opportunities to invest in early stage life science companies within markets with significant demand and growth potential. The scope of investment opportunities extends beyond prescription drugs to any commercial application of proprietary technology that originates from a key advance in biology or chemistry, including: Therapeutics / Diagnostics, Medical Devices, Aesthetic and Medical Dermatology, Drug Delivery Platforms, Industrial / Chemical Reactions, Optical Displays, Agriculture / Plant Microbiome, DNA Sequencing, and Pulmonary Delivery.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
